– USA, NY – Phreesia, the nation’s leading patient intake management platform, today announced the nomination of Lainie Goldstein to its Board of Directors as a new member effective July 20.
Ms. Goldstein is the CFO of Take-Two Interactive Software, Inc., a leading global interactive entertainment company, where she oversees finance, investor relations and corporate communications.
“We’re honored and excited to welcome Lainie to our board,” said CEO Chaim Indig. “Her extensive leadership, business and financial expertise across a broad range of industries will be a great asset to our company as we continue developing products that help to create a better healthcare experience.”
About Lainie Goldstein
Ms. Goldstein is a CPA with more than 30 years of financial and business experience in the software, entertainment, retail and apparel industries. Prior to joining Take-Two, she was Vice President of Finance and Business Development at Nautica Enterprises, Inc. She also worked in the audit and reorganization departments at Grant Thornton LLP.
“I firmly believe that the use of digital technologies can help to improve patients’ experiences and outcomes,” said Ms. Goldstein. “Phreesia is a dynamic, nimble company that can quickly deliver solutions for its clients and their patients, and I am excited to support the company’s long-term growth and expansion.”
About Phreesia
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, consistent experience while enabling healthcare organizations to enhance clinical care and drive efficiency.
For more information: https://www.phreesia.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
